Compounds > phenobarbital

phenobarbital and metaproterenol

phenobarbital has been researched along with metaproterenol in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19904 (50.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's2 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Topliss, JG; Yoshida, F1
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Marvola, M1
Stewart, CJ; Wells, FO1
Pabst, K; Winkelmann, G1
Grosser, KD; Humpert, U1

Reviews

1 review(s) available for phenobarbital and metaproterenol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

7 other study(ies) available for phenobarbital and metaproterenol

ArticleYear
QSAR model for drug human oral bioavailability.
    Journal of medicinal chemistry, 2000, Jun-29, Volume: 43, Issue:13

    Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship

2000
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
    Journal of medicinal chemistry, 2008, Oct-09, Volume: 51, Issue:19

    Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship

2008
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Effect of acetylated derivatives of some sympathomimetic amines on the acute toxicity, locomotor activity and barbiturate anaesthesia time in mice.
    Acta pharmacologica et toxicologica, 1976, Volume: 38, Issue:5

    Topics: Acetylation; Amphetamine; Animals; Ephedrine; Lethal Dose 50; Male; Metaproterenol; Mice; Motor Activity; Phenobarbital; Phenylephrine; Sleep; Sympathomimetics; Tyramine

1976
Problems with asthma.
    British medical journal, 1972, Jul-01, Volume: 3, Issue:5817

    Topics: Adult; Antifungal Agents; Asthma; Candida albicans; Candidiasis; Candidiasis, Oral; Ephedrine; Humans; Male; Metaproterenol; Phenobarbital; Physician-Patient Relations; Sputum; Theophylline

1972
[Treatment of cardiogenic shock].
    Minerva medica, 1973, Dec-26, Volume: 64, Issue:93

    Topics: Bicarbonates; Cardiac Glycosides; Dextrans; Diazepam; Heparin; Humans; Metaproterenol; Norepinephrine; Phenobarbital; Phenothiazines; Shock, Cardiogenic

1973
[On the therapy of the combination form of Adams-Stokes syndrome with orciprenaline].
    Zeitschrift fur Kreislaufforschung, 1966, Volume: 55, Issue:10

    Topics: Adams-Stokes Syndrome; Aged; Bronchodilator Agents; Electric Countershock; Female; Humans; Meperidine; Metaproterenol; Phenethylamines; Phenobarbital; Phytotherapy; Plants, Medicinal; Procainamide; Quinidine; Rauwolfia; Resorcinols; Ventricular Fibrillation

1966